Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,442 | -21,278 | -41,097 | -38,920 | 1,370 |
| Depreciation Amortization | 5,147 | 8,670 | 7,695 | 9,362 | 4,730 |
| Income taxes - deferred | N/A | N/A | 8,891 | -3,975 | -2,405 |
| Accounts receivable | -7,542 | -826 | 1,932 | 16,325 | -5,741 |
| Other Working Capital | -6,957 | 785 | 21,312 | 9,532 | -205 |
| Other Operating Activity | 14,753 | -5,645 | -1,133 | -14,553 | 11,655 |
| Operating Cash Flow | $-5,041 | $-18,294 | $-2,400 | $-22,229 | $9,404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,796 | -1,721 | -3,762 | -8,167 | -4,991 |
| Net Acquisitions | 24,286 | 43,384 | -473 | -9,443 | -525 |
| Other Investing Activity | -31 | -1,280 | -1,954 | 0 | 0 |
| Investing Cash Flow | $22,459 | $40,383 | $-6,189 | $-17,610 | $-5,516 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 302 | -4,661 | 3,481 | 594 | -14,013 |
| Debt Issued | N/A | 23,600 | 30,000 | 12,000 | 2,300 |
| Debt Repayment | -20,276 | -22,515 | -16,129 | -4,775 | -8,279 |
| Common Stock Issued | 92 | 308 | 7,242 | 2,800 | 609 |
| Common Stock Repurchased | -29 | -14 | -30 | N/A | N/A |
| Other Financing Activity | -9,889 | -12,761 | -5,072 | 9,534 | -1,567 |
| Financing Cash Flow | $-29,800 | $-16,043 | $19,492 | $20,153 | $-20,950 |
| Exchange Rate Effect | -166 | 1,429 | 802 | -451 | 1,625 |
| Beginning Cash Position | 21,651 | 16,143 | 5,912 | 27,940 | 43,377 |
| End Cash Position | 8,816 | 21,651 | 16,397 | 7,803 | 27,940 |
| Net Cash Flow | $-12,835 | $5,508 | $10,485 | $-20,137 | $-15,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,041 | -18,294 | -2,400 | -22,229 | 9,404 |
| Capital Expenditure | -1,803 | -1,721 | -5,068 | -8,167 | -5,036 |
| Free Cash Flow | -6,844 | -20,015 | -7,468 | -30,396 | 4,368 |